Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2010

01-06-2010 | Original Article

Tracking Abnormal Cervical Cancer Screening: Evaluation of an EMR-Based Intervention

Authors: Elizabeth A. Dupuis, MD, Hilary F. White, Daniel Newman, MD, Jerome E. Sobieraj, MD, Manjusha Gokhale, MA, Karen M. Freund, MD, MPH

Published in: Journal of General Internal Medicine | Issue 6/2010

Login to get access

Abstract

INTRODUCTION

System level barriers have been associated with inadequate follow-up of abnormal cervical cytology.

OBJECTIVE

The aim of this study was to develop and evaluate an electronic tracking system to improve follow-up of abnormal Pap tests.

PROGRAM DESCRIPTION

We implemented an electronic medical record (EMR)-based Pap test tracking system at two clinical practices at an inner-city academic health center. The system generated a provider-specific monthly report of all abnormal Pap results, and provided a patient-specific Pap tracking table embedded in the EMR for each subject.

EVALUATION

We compared abnormal Pap test follow-up rates for the 24 months pre-intervention with rates 12 months following its implementation (post-intervention). The evaluation followed all subjects for 12 months from the date of their abnormal Pap test, looking for diagnostic resolution.

RESULTS

Subjects were young women (mean age = 30.5) of primarily white (42%) and African American (37%) descent, who spoke English (88%). Forty-eight percent were insured through publicly subsidized insurance. Controlling for type of abnormality and practice location, the adjusted mean time to resolution decreased significantly from 108 days (confidence interval, CI 105–112 days) in the pre-intervention period to 86 days (CI 81–91 days).

CONCLUSION

Our study cannot demonstrate that with follow up, we directly avoided cases of invasive cervical cancer. However, we show that in an at-risk urban population, an automated, EMR-based tracking system reduced the time to resolution, and increased the number of women who achieved diagnostic resolution.
Literature
2.
go back to reference Schiffman MH, Brinton LA, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996:1090–116. Schiffman MH, Brinton LA, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996:1090–116.
3.
go back to reference Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95(9):825–32.PubMed Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95(9):825–32.PubMed
4.
go back to reference Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–83.PubMedCrossRef Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–83.PubMedCrossRef
5.
go back to reference Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30(3):216–30.CrossRefPubMed Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30(3):216–30.CrossRefPubMed
6.
go back to reference Cartwight PS, Reed G. No-show behavior in a county hospital clinic. Am J Gynecol Health. 1990;6:15–21. Cartwight PS, Reed G. No-show behavior in a county hospital clinic. Am J Gynecol Health. 1990;6:15–21.
7.
go back to reference Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J. 1992;85(1):5–8.PubMed Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J. 1992;85(1):5–8.PubMed
8.
go back to reference Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract. 1983;17(5):811–7.PubMed Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract. 1983;17(5):811–7.PubMed
9.
go back to reference Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37(6):583–7.PubMed Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37(6):583–7.PubMed
10.
go back to reference Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in Manchester. Br Med J (Clin Res Ed). 1988;296(6628):1041–2.CrossRef Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in Manchester. Br Med J (Clin Res Ed). 1988;296(6628):1041–2.CrossRef
11.
go back to reference Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19(6):630–41.CrossRefPubMed Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19(6):630–41.CrossRefPubMed
12.
go back to reference Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9.CrossRefPubMed Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9.CrossRefPubMed
13.
go back to reference Townsend RW. Formation and operation of a captive insurance company for malpractice coverage. Coll Rev. 1988;5:47–61.PubMed Townsend RW. Formation and operation of a captive insurance company for malpractice coverage. Coll Rev. 1988;5:47–61.PubMed
14.
go back to reference National Committee for Quality Assurance (NCQA). Standards and Guidelines for Physician Practice Connections - Patient-Centered Medical Home (PPC-PCMH): 2008. National Committee for Quality Assurance (NCQA). Standards and Guidelines for Physician Practice Connections - Patient-Centered Medical Home (PPC-PCMH): 2008.
15.
go back to reference Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl):15–38.CrossRefPubMed Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl):15–38.CrossRefPubMed
16.
go back to reference Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–67.CrossRefPubMed Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–67.CrossRefPubMed
Metadata
Title
Tracking Abnormal Cervical Cancer Screening: Evaluation of an EMR-Based Intervention
Authors
Elizabeth A. Dupuis, MD
Hilary F. White
Daniel Newman, MD
Jerome E. Sobieraj, MD
Manjusha Gokhale, MA
Karen M. Freund, MD, MPH
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 6/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1287-z

Other articles of this Issue 6/2010

Journal of General Internal Medicine 6/2010 Go to the issue

Healing Arts

Room with a View

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.